Patents & CI News: 26/01/2011


1) Watson Confirms Welchol(R) Oral Suspension Patent Challenge (press release); View on RFC. Impax may be first to file for Colesevelam HCI powder for oral suspension.

2) Amgen Buys a Cancer Drug Maker (link)

3) Sanofi-Aventis in-licenses Oxford BioTherapeutics antibody for the treatment of solid cancers (the pharma letter)

4) Mylan Announces settlement agreement Lipitor & Caduet (Yahoo finance 1) (Yahoo finance 2)

5) Teva Receives FDA Action Letter (deficiency letter) For Generic Lovenox® (enoxaparin sodium) inj. Sandoz is the first generics for enoxaparin.

6) Fexofenadine is approved for OTC use for allergy in USA (Sanofi)

7) US complaint: Warner Chilcott v. Teva Pharmaceuticals (product: probably risedronate) View on RFC express

8) Merck Funds India Project for Vaccine to Rival Its Own, FT Says (Bloomberg)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s